Stereotactic ablative radiotherapy for medically inoperable early stage lung cancer: Early outcomes

Hong Kong Medical Journal

Volumn 18, Issue 5, 2012, Pages 412-418

  Chan, Oscar S H ^a   Yeung, Rebecca M W ^a   Hung, Albert W M ^a   Lee, Michael C H ^a   Chang, Amy T Y ^a   Chan, Connie C C ^a   Lee, Anne W M ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Carcinoma; Lung neoplasms; Non small cell lung; Radiotherapy; Stereotaxic techniques; Survival rate

Indexed keywords

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMORBIDITY; DISEASE CONTROL; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HONG KONG; HUMAN; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALE; OVERALL SURVIVAL; PRIMARY TUMOR; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTAXIC SURGERY; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84870952632     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003;41:1-11.
2. Crinò L, Weder W, van Meerbeeck J, Felip E; ESMO Guidelines Working Group. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21 Suppl 5:v103-15.
3. Flores RM, Park BJ, Dycoco J, et al. Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. J Thorac Cardiovasc Surg 2009;138:11-8.
4. Roviaro G, Varoli F, Vergani C, Nucca O, Maciocco M, Grignani F. Long-term survival after videothoracoscopic lobectomy for stage I lung cancer. Chest 2004;126:725-32.
5. Okada M, Nishio W, Sakamoto T, et al. Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection. Ann Thorac Surg 2004;77:1926-30; discussion 1931.
6. Lax I, Blomgren H, Näslund I, Svanström R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994;33:677-83.
7. Blomgren H, Lax I, Naslund I, Svanström R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-70.
8. Timmerman RD, Solberg TD, Kavanagh BD, Lo SS. Stereotactic techniques for lung cancer treatment. In: Pass HI, Carbone DP, Johnson DH, Scagliotti GV, Minna JD, Turrisi AT, editors. Principles and practice of lung cancer. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2010: 589-600.
9. Loo BW, Chang JY, Dawson LA, et al. Stereotactic ablative radiotherapy: what's in a name? Pract Radiat Oncol 2011;1:38-9.
10. Nagata Y, Wulf J, Lax I, et al. Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2011;79:660-9.
11. De Ruysscher D, Faivre-Finn C, Nestle U, et al. European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol 2010;28:5301-10.
12. Senan S, De Ruysscher D, Giraud P, Mirimanoff R, Budach V; Radiotherapy Group of European Organization for Research and Treatment of Cancer. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 2004;71:139-46.
13. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-6.
14. Green MR, Ginsberg R, Ardizzoni A, et al. Induction therapy for stage III NSCLC: a consensus report. Lung Cancer 1994;11 Suppl 3:S9-10.
15. Ng AW, Tung SY, Wong VY. Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer-report on clinical outcome and dose to critical organs. Radiother Oncol 2008;87:24-8.
16. Fowler JF, Tome WA, Welsh JS. Estimation of required doses in stereotactic body radiation therapy. In: Kavanagh BD, Timmerman RD, editors. Stereotactic body radiation therapy. Philadelphia: Lippincott Williams & Wilkins; 2005: 7-14.
17. Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Palmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol 1999;52:137-48.
18. Kestin LL, Grills IS, Guckenberger M, et al. Substantial dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance. Int J Radiat Oncol Biol Phys 2011;78:S14.
19. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623-31.
20. Sher DJ, Wee JO, Punglia RS. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2011;81:e767-74.
21. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope 2000;110:593-602.
22. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004;291:2441-7.
23. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 2010;28:5153-9.
24. Ong CL, Verbakel WF, Cuijpers JP, Slotman BJ, Lagerwaard FJ, Senan S. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques. Radiother Oncol 2010;97:437-42.